Basics Acrivon Therapeutics, Inc. IPO Date: November 15, 2022 Sector: Healthcare Industry: Biotech Market Cap: $74.79M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 3.98% Avg Daily Range (30 D): $0.08 | 3.92% Avg Daily Range (90 D): $0.06 | 3.49% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .87M Avg Daily Volume (90 D): 1.09M Trade Size Avg Trade Size (Sh.): 139 Avg Trade Size (Sh.) (30 D): 180 Avg Trade Size (Sh.) (90 D): 224 Institutional Trades Total Inst.Trades: 21 Avg Inst. Trade: $2.21M Avg Inst. Trade (30 D): $.56M Avg Inst. Trade (90 D): $.56M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.11M Avg Closing Trade (30 D): $1.11M Avg Closing Trade (90 D): $1.11M Avg Closing Volume: 320.84K     News Jul 15, 2025 @ 5:00 PM Endometrial Cancer Clinical Trial Pipeline Insight... Source: Delveinsight Sep 14, 2024 @ 7:10 AM Acrivon Therapeutics Reports Positive Endometrial ... Source: N/A Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A Jul 5, 2024 @ 1:31 PM AstraZeneca's (AZN) Tagrisso Gets EU Nod for First... Source: N/A Jul 2, 2024 @ 4:12 PM SpringWorks (SWTX) Completes NDA Submission for Mi... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.12 $-.47 Diluted EPS $-2.12 $-.47 Revenue $ M $ M $ Gross Profit $ $ $ Net Income / Loss $ -81.75M $ -18.23M $ -21.01M Operating Income / Loss $ -88.95M $ -19.69M $ Cost of Revenue $ $ $ Net Cash Flow $ -8M $ $ PE Ratio